Discontinued — last reported Q4 '23
GRAIL Inc — Accumulated impairment loss
Illumina GRAIL Inc — Accumulated impairment loss increased by 18.2% to $4.63B in Q4 2023 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increase in accumulated impairment loss indicates that the company has recognized significant declines in the expected future economic benefits of the segment's assets, often signaling past overvaluation or deteriorating business prospects. A stable figure suggests that the current asset valuations are being maintained without further downward adjustments.
Detailed definition
This metric represents the total cumulative reduction in the carrying value of assets associated with the GRAIL business...
Peer comparison
Comparable to 'Accumulated Goodwill Impairment' or 'Asset Write-downs' reported by peers in the life sciences or diagnostics sectors that have undergone significant M&A activity or divestitures.
ilmn_segment_grail_inc_accumulated_impairment_lossHistorical Data
| Q4 '22 | Q4 '23 | |
|---|---|---|
| Value | $3.91B | $4.63B |
| QoQ Change | — | +18.2% |
| YoY Change | — | +18.2% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Illumina's grail inc — accumulated impairment loss?
- Illumina (ILMN) reported grail inc — accumulated impairment loss of $4.63B in Q4 2023.
- What does grail inc — accumulated impairment loss mean?
- The total amount of value lost over time due to accounting write-downs of assets within the GRAIL business segment.